Scientific article

Est-il actuellement fondé de proposer un dépistage du cancer de la prostate? Questions-réponses

Published inRevue médicale suisse, vol. 8, no. 365, p. 2331-2334
Publication date2012

Prostate cancer is the most frequently non-dermatologic tumor diagnosed in Europe. The validity of its screening has been demonstrated by 2 prospective randomized studies including over 160000 patients. However, prostate cancer screening remains controversial because it may lead to overtreatment; moreover, some patients may experience significant functional side effects after surgery and radiotherapy. Integrating this with the individual health situation leads to invite patients to early diagnosis once substantial information has been provided. If cancer is diagnosed, its management is recommended in a multidisciplinary center whose recruitment volume is significant.

  • Early Detection of Cancer
  • Humans
  • Male
  • Mass Screening
  • Prostatic Neoplasms/prevention & control
  • Randomized Controlled Trials as Topic
  • Risk Assessment
Citation (ISO format)
ISELIN, Christophe, WIRTH, Grégory Johann. Est-il actuellement fondé de proposer un dépistage du cancer de la prostate? Questions-réponses. In: Revue médicale suisse, 2012, vol. 8, n° 365, p. 2331–2334.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation05/15/2013 1:15:00 PM
First validation05/15/2013 1:15:00 PM
Update time03/14/2023 8:10:56 PM
Status update03/14/2023 8:10:56 PM
Last indexation01/16/2024 1:38:51 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack